Abbott launches automation solutions GLP systems Track to support laboratories’ high-volume needs – ET HealthWorld

Abbott launches automation solutions GLP systems Track to support laboratories’ high-volume needs – ET HealthWorld

Delhi: Abbott announced the launch of its innovative automation solutions, GLP systems Track, to support laboratories’ high-volume needs. India is now the world’s most populous nation, and the population is experiencing a rising chronic disease burden. As a result, the Indian diagnostic sector is expected to grow at a compound annual growth rate of 11 … Read more

Abbott launches FreeStyle LibreLink mobile app – ET HealthWorld

Abbott launches FreeStyle LibreLink mobile app – ET HealthWorld

Mumbai: Abbott has introduced the FreeStyle LibreLink app in India, providing users of the FreeStyle Libre glucose monitoring system the convenience of checking their readings on their mobile phones without the need for finger pricking. The app is compatible with both iPhone and Android smartphones, offering real-time glucose data and the ability to easily share … Read more

FDA: Unsanitary Conditions Found at Baby Food Factory

FDA: Unsanitary Conditions Found at Baby Food Factory

March 23, 2022 U.S. Food and Drug Administration investigators found unsanitary conditions at an Abbott baby food factory in Sturgis, MI., linked to reports of bacterial infections in infants, the FDA said in a preliminary report issued Tuesday. The report said Abbott didn’t maintain clean surfaces at the plant and that inspectors found a history … Read more

FDA Expands Recall of Abbott Baby Formula

FDA Expands Recall of Abbott Baby Formula

March 1, 2022 The U.S. Food and Drug Administration expanded its recall of Abbott baby formula after a second infant became sick with a bacterial infection and died after consuming formula. The newest recall is for Similac PM 60/40 formula, a specialty formula for infants who need lowered mineral intake, the FDA said in a … Read more

Diseases of heart are complex, success depends on innovation: Payal Agrawal, Structural Heart Division Abbott

Heart Defects

The pandemic has had unprecedented effects on the healthcare system globally, and in India. Like with other diseases, cardiac care has also been affected. Congenital Heart Disease (CHD) refers to a problem with the heart’s structure that is present at birth. Such defects are not rare; more than 200,000 children are estimated to be born … Read more

Abbott launches Panbio COVID-19 antigen self-test in India to support testing needs at home, work and clinics Our 

Abbott Panbio covid 19 self test kit

The Panbio COVID-19 Antigen Self-Test is easy-to-use, and people can take the test by using a simple nasal swab (not the deep nasopharyngeal swab) while following the Instructions for Use steps on pack. Abbott has announced the launch of Panbio COVID-19 Antigen Self-Test for the detection of the SARS-CoV-2 virus in adults and children with … Read more

API launches therapy-specific teleconsultation recommendations – ET HealthWorld

api launches therapy specific teleconsultation recommendations

Mumbai, July 01, 2021: The Association of Physicians of India (API) has launched therapy-specific teleconsultation recommendations, in collaboration with Abbott. This robust set of recommendations outlines best practices on adopting teleconsultation across various therapeutic areas, currently catering specifically to cardiology, diabetes, gastroenterology and adult immunization with plans to cover more specialties in the future. The … Read more

Delhi HC to hear over 50 petitions against anti-profiteering provisions under GST

photo

MUMBAI: In what could decide the fate of anti-profiteering provisions under the Goods and Services Tax (GST) framework, the Delhi High Court will Monday hear petitions filed by more than 50 top companies against this mechanism. Hindustan Unilever, Abbott, Johnson & Johnson, Philips, Patanjali, Samsonite, Jubilant Foods, and Nestle are among those that dragged the … Read more